Today's Small Cap Stocks Pulse
Deep Fission targets up to $1.66B valuation in new Nasdaq IPO
Deep Fission announced a Nasdaq IPO seeking $157 million at $24‑$26 per share, which would value the nuclear startup at up to $1.66 billion. The company previously completed a reverse merger that raised $30 million but never traded on the OTCQB. Its latest S‑1 filing shows a cash deficit of $88.1 million as of March, up from $56.2 million in December.
Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025
Mannatech reported a Q4 2025 net loss of $11.3 million, reversing a $2.3 million profit from the same quarter a year earlier. Full‑year net sales fell 8.3% to $108 million, while gross profit margin slipped to roughly 75% from 80% in 2024. A $12.3 million income‑tax charge, largely from deferred‑tax adjustments, drove the annual net loss to $15.2 million. Cash and cash equivalents dropped to $6.2 million, about half of the prior‑year balance.
VB: Small Caps Join The Breakout Party
Vanguard’s Small‑Cap ETF (VB) surged to $284.67 on April 17, posting a 1.82% gain and setting a fresh all‑time high that outpaced the S&P 500. The fund trades at roughly 16 times forward earnings, well below the historical small‑cap premium, and analysts...
How Low-Fee Small-Cap Value ETF, ACSV, Has Outperformed Small Caps YTD
The American Century Small Cap Value Insights ETF (ACSV) has posted a 10.37% year‑to‑date return, outpacing both the S&P 500 and the Dow Jones U.S. Small‑Cap Value Index, which is up 5.55% YTD. ACSV charges a zero‑basis‑point expense ratio and employs...
Hive Digital Technologies Shares Drop 12% After $75 Million Note Offering
Hive Digital Technologies (HIVE) saw its shares tumble nearly 12% on Thursday after the miner disclosed a $75 million senior‑note financing. The capital raise, aimed at buying GPUs and expanding data‑center capacity, sparked concerns over dilution and the company’s cash‑burn trajectory.
Chino Commercial Bancorp Reports 24.7% Increase in Net Earnings
Chino Commercial Bancorp reported first‑quarter net earnings of $1.69 million, a 24.7% year‑over‑year increase, lifting basic and diluted EPS to $0.52. Net interest margin rose to 4.15% from 3.50% a year earlier, driven by higher loan and investment‑securities income. Total assets...
Flexible Solutions International, Inc. (FSI) Q4 2025 Earnings Call Transcript
Flexible Solutions International’s CEO Dan O’Brien used the Q4 2025 earnings call to highlight a strategic pivot in its NanoChem (NCS) division, which now generates the bulk of the company’s revenue. NCS launched food‑grade operations in 2022 and is on track...
Madison Dearborn’s Aevex Drone Play Takes Off in IPO
Aevex, the Madison Dearborn Partners‑backed drone manufacturer, launched an initial public offering on April 17, 2026 that valued the company at more than $2 billion. The Chicago firm bought Aevex in 2020 for $450 million, including debt, and still holds a controlling...
EVgo: It Is Getting Very Attractive As Operations Nearing Breakeven
EVgo, Inc. reported a 49% year‑over‑year revenue surge in FY 2025, driven by strong ancillary and charging‑segment sales. The company posted positive adjusted EBITDA of $25 million in Q4 and lifted its gross margin to 46%, while holding $151 million in cash against...
Decibel Cannabis Posts 22% Revenue Growth to $113M, Unveils Aggressive Go‑to‑Market Plan
Decibel Cannabis Company announced FY2025 net revenue of $113 million, a 22% increase year‑over‑year, and outlined a multi‑pronged go‑to‑market strategy. The company highlighted a 484% jump in international sales, a new Standard Issue brand, and a debt refinance that positions it...
Allbirds Shares Surge 600% After $50M AI Pivot and Rebrand to NewBird AI
Allbirds Inc. announced a $50 million convertible financing deal and the sale of its footwear business for $39 million, then rebranded as NewBird AI to launch a GPU‑as‑a‑Service platform. The news sent the stock up more than 600%, igniting fierce discussion about...
Kailera IPO Interview: CEO Renaud Talks Biotech Market, China and Obesity Pipeline
Kailera Therapeutics closed a record‑setting $625 million Nasdaq IPO, the largest biotech debut of the year. The company, launched with Bain Capital Life Sciences backing, leverages a portfolio of obesity drug candidates originally sourced from China’s Hengrui Medicine. CEO Renaud highlighted...
Decibel Cannabis Q4 FY25 Update – DB.v/ DBCCF
Decibel Cannabis reported Q4 FY25 revenue of CAD 28.7 million ($21 million USD), a 13% year‑over‑year increase, while full‑year revenue rose 22% to CAD 112.7 million ($83 million USD). International sales exploded, up 116% YoY to CAD 7.4 million ($5.5 million USD) in the quarter and representing 27% of...
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
RBC Capital trimmed its price target for Karyopharm Therapeutics (KPTI) to $16 from $23, citing short‑term seasonal pressures such as reimbursement resets, fewer selling days and weather‑related disruptions that could weigh on newly launched, clinic‑administered products. The brokerage kept an...
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
RBC Capital trimmed its price target for Karyopharm Therapeutics (KPTI) to $16 from $23, flagging short‑term seasonal pressures such as reimbursement resets, fewer trading days and weather‑related disruptions that could dampen sales of newly launched, clinic‑administered products. The firm kept...
Evercore Maintains Positive Stance on MeiraGTx Holdings Plc (MGTX) Amid Sector Revisions
Evercore ISI analyst Gavin Clark‑Gartner lowered his price target for MeiraGTx Holdings (MGTX) from $20 to $18 while maintaining an Outperform rating, part of a sector‑wide revision of small‑ and mid‑cap biotech firms. The adjustment follows the FDA’s recent Breakthrough...
Evercore Maintains Positive Stance on MeiraGTx Holdings Plc (MGTX) Amid Sector Revisions
Evercore ISI analyst Gavin Clark‑Gartner lowered MeiraGTx Holdings plc’s price target to $18 from $20 while retaining an Outperform rating. The adjustment was part of a sector‑wide review of small‑ and mid‑cap biotech firms ahead of second‑quarter catalysts. Earlier this...
Morgan Stanley Updates Bicycle Therapeutics Plc (BCYC) Outlook Amid Pipeline Refocus
Morgan Stanley cut its price target for Bicycle Therapeutics plc (BCYC) to $12 from $13 while maintaining an Equal‑Weight rating, citing the company’s strategic refocus on BT5528 and next‑generation Bicycle conjugate programs. The revision also reflects a roughly 30% workforce...
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
Jefferies lowered its price target for Arbutus Biopharma (ABUS) from $7.00 to $5.50 while keeping a Buy rating, citing a higher probability that Moderna will win its appeal in a patent dispute. The appeal outcome affects a potential $1.3 billion contingent...
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
Jefferies lowered its price target for Arbutus Biopharma (ABUS) to $5.50 from $7.00, citing a higher probability that Moderna will win its appeal in a patent dispute. The outcome affects a potential $1.3 billion contingent payment tied to the case, while...
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value
Mizuho Securities raised its price target on Corbus Pharmaceuticals (CRBP) to $40 from $39 and kept an Outperform rating after the company’s Q4 results. The broker noted the stock is trading close to Corbus’s cash balance, implying limited downside risk....
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value
Mizuho Securities raised its price target on Corbus Pharmaceuticals (CRBP) to $40, maintaining an Outperform rating after the company’s fourth‑quarter results. The firm highlighted that CRBP is trading near its cash balance, which it says caps downside risk. Mizuho expects...
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
Jefferies downgraded Replimune Group (NASDAQ:REPL) from Buy to Hold and slashed its price target to $2 after the FDA issued a complete response letter on the RP1 oncolytic therapy. The FDA’s feedback diverged from earlier Type A meeting guidance, raising...
Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions
Evercore ISI trimmed Fortrea Holdings (FTRE) price target to $14 from $25 while keeping an Outperform rating, citing revised near‑term assumptions in its Q1 healthcare technology update. The change coincides with FTRE’s launch of Fortrea Intelligent Technology (FIT), an AI‑enabled...
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
Wolfe Research has initiated coverage of Palisade Bio (NASDAQ:PALI) with an Outperform rating and a $7 price target, signaling confidence in the company’s long‑term prospects despite limited near‑term activity. The firm highlighted Phase 1b data for the oral PDE4 prodrug PALI‑2108,...
Archer Aviation Clears Key FAA Hurdle but Faces Dilution and Execution Risks
Archer Aviation announced full FAA acceptance of its Midnight aircraft’s Means of Compliance, bolstering its path to certification. The eVTOL maker still carries a $618 million net loss, $2 billion cash balance and ongoing dilution, leaving investors to judge upside against high...
Allbirds' $50M AI Pivot Sends Stock 600% Higher, Sparks Skepticism
Allbirds announced a $50 million financing deal to rebrand as NewBird AI and exit the footwear market after selling its assets for $39 million. The news sent the stock soaring more than 600% in a single day, igniting a clash between investors...
Lakeland Posts 15% Revenue Rise in Q4 2026 as CRO Barry Phillips Charts Growth Path
Lakeland Industries reported full‑year net sales of $192.6 million, a 15.2% increase, while fourth‑quarter sales slipped 1.7% to $45.8 million. Chief Revenue Officer Barry Phillips used the earnings call to detail a fire‑services‑focused growth strategy, new acquisitions and a $130 million pipeline, even...
Manycore Tech Jumps Up to 187% in Hong Kong IPO, Showcasing Chinese AI Startup Surge
Manycore Tech, a Hangzhou‑based AI and design software firm, surged as much as 187% on its Hong Kong IPO debut, raising roughly US$160 million. The jump highlights strong demand for Chinese AI startups and the company’s push into "spatial intelligence."
Alamar Biosciences Upsizes IPO, Raises $191.3 M to Accelerate Cell‑Based Drug Discovery
Alamar Biosciences priced an upsized initial public offering of 11.25 million shares at $17 each, generating $191.3 million in gross proceeds. The capital will fund the expansion of its cell‑based drug discovery platform, positioning the company for broader partnerships and a Nasdaq...
ConnectM Delivers 93% Gross Profit Growth in Transformational Fiscal Year 2025; Targets $75 Million Revenue and Positive EBITDA for Fiscal...
ConnectM Technology Solutions reported a transformational fiscal 2025, posting record revenue of $35.8 million, a 58% jump from the prior year, and a 93% surge in gross profit to $11.5 million, lifting gross margin to 32%. The company reversed a $23.8 million equity...
USB Q1 Shows Solid Growth, Beats NII Estimates
USB's Q1 earnings: solid growth, but no big surprises. Net interest income beat estimates, credit is strong, and the Union Bank merger is done. A steady, reliable play. BankStocks
Chemung Financial Corporation Reports Record Quarterly Results; First Quarter 2026 Net Income of $9.2 Million, or $1.91 per Share
Chemung Financial Corp posted a record first‑quarter 2026 net income of $9.2 million, or $1.91 per share, beating both the prior quarter and the same period last year. The bank’s adjusted efficiency ratio fell to a historic low 58.27%, while loan...
Apollo Micro Soars 16% After Missile Licence Approval
Apollo Micro Systems jumps 16% after bagging government licence to make missiles, munitions The authorization covers advanced defense equipment including missiles, torpedoes, and loitering munitions with significant production capacity at dedicated Hyderabad facilities.
Pixelworks Uses $5M Buyback to Signal Licensing Pivot
Pixelworks $PXLW announced a $5m buyback, roughly 14% of its market cap. The company recently closed the sale of its semicon sub, which adds $51m to its $11m balance sheet. Not bad. Pixelworks is pivoting towards a ‘technology licensing specializing...
Kailera Raises $625M IPO in Biotech Record
Kailera Therapeutics completed a $625 million IPO, establishing a new biotech record and eclipsing Moderna’s 2018 $604 million debut. The offering, led by Goldman Sachs, JPMorgan and Morgan Stanley, attracted strong institutional demand and priced above expectations. Proceeds will fund Kailera’s gene‑editing...
Long-Term Investment Thesis on HIMS and Peptides
This video shows part of my $RDDT investment thesis or you can click on this link for the full interview https://t.co/X7jWOIisLu I’ll be doing more interviews like this in the coming weeks… so I can walk through the investment thesis on...
15‑Minute Opening Range Break Profits $CAR Long
$CAR made some money back on the long side. Literally all you have to do is play a 15 minute opening range break.
Bison Resources IPO Soars 375% on First Day, Signaling Aussie Mining Listing Revival
Bison Resources listed on the Australian Securities Exchange on Thursday, raising $5.5 million at A$0.20 per share and rocketing 375% to A$0.95 by Friday. The surge marks the strongest first‑day performance among recent Aussie mining listings and fuels speculation of a...
EFOI Surges 330% on First Data Center Contract
$EFOI up 330% on its first data center contract announcement. Interestingly, it's 10K filed in March revealed the first signs. I unfortunately wrote it off due to horrible past executions issues. But still shows the power of InfoArb. PR:...
NorthStar E&S Targets $300M Valuation in SPAC IPO
Space-based space situational awareness co @NorthStarEandS to IPO on @NYSE via merger with SPAC #VikingAcquisition. Minimum gross proceeds of $30M, pre-money valuation $300M. @SpireGlobal @LuxSpaceAgency @CartesianCap. https://t.co/coJbF6PboG https://t.co/leePWtbfAm
Kailera Therapeutics Prices $625 M IPO at $16 per Share
Kailera Therapeutics announced the pricing of its initial public offering at $16 per share, aiming to raise roughly $625 million. The 39.06 million‑share offering, with a 30‑day over‑allotment option, will debut on the Nasdaq Global Select Market under the ticker KLRA.
NorthStar Satellite Analytics Secures $30M PIPE, $405M Valuation
NorthStar / Viking Acquisition I deal overview Space and satellite data analytics company $405 million enterprise value $30 million PIPE Closing Q3 Symbol $NSTR PR: https://t.co/v61y0ElAJP IR deck: https://t.co/mosqCqKlMZ Disclosure: Long $VACI shares + warrants in $ARB.to https://t.co/CTqRus69vb
Bear of the Day: Dave & Buster's (PLAY)
Dave & Buster's (PLAY) remains entrenched in the lower tier of the Zacks Rank as its stock trades below $20. The company posted a Q2 EPS of $0.40, a 64% drop from a year earlier, missing the $0.88 consensus. In...
Viking Therapeutics Gains Strong‑Buy Consensus as Obesity Market Eyes $100B by 2030
Wall Street analysts have given Viking Therapeutics (VKTX) an average brokerage recommendation of 1.33, bordering on a strong buy, as its GLP‑1 obesity candidates move through phase‑3 trials. The stock’s 121% one‑day surge in early 2024 and a $100 billion market...
Barry FitzGerald: Multi-Billion Dollar Guyana Gold Deal Places $240m ASX Explorer in the Spotlight
Altair Minerals (ASX:ALR) secured up to a 70% stake in Guyana's Greater Oko gold project last August, but only recently has the deal attracted market attention. The catalyst was the $C3 billion (≈US$2.2 b) acquisition of G2 Goldfields by TSX‑listed G Mining...
Bluestone Grants Fresh ESOPs Worth Rs 11 Cr
BlueStone has issued fresh employee stock options worth roughly Rs 11 crore (~$1.3 million), representing 209,319 shares under its 2014 ESOP scheme. The options vest over four years, with 25 % unlocking after the first year and the remainder monthly thereafter. This grant follows...
Manycore Shares up as Much as 185% in First Day of Hong Kong Trading
Manycore Tech, a Hangzhou‑based spatial design software maker, debuted on the Hong Kong Stock Exchange and saw its shares jump as much as 185% on the first day of trading. The company raised HK$1.22 billion (about US$156 million) by selling 160.6 million shares...
Mehul Telecom IPO Opens for Subscription. Check GMP, Price Band, and Other Details
Mehul Telecom's SME IPO opened on April 17, 2026 with a price band of ₹96‑₹98 per share and a grey‑market premium of about 4%, suggesting a potential listing price near ₹102 ($1.23). The issue, a fully fresh issue of 28.29 lakh...
The IPO Buzz: Alamar Biosciences (ALMR) Upsizes IPO & Prices It at $17 – High End
Alamar Biosciences (ALMR) upsized its IPO to 11.25 million shares and priced at the top of its range, $17 per share, raising about $191.25 million. The offering values the company at roughly $1.14 billion as it prepares to debut on Nasdaq on April 17....
Global Momentum Continues as Immuron Delivers Double-Digit Q3 Sales Growth in Australia
Immuron (ASX: IMC) posted a strong third‑quarter for its Travelan probiotic, with Australian sales climbing to AUD 0.9 million (≈ $0.6 million), a 15% rise YoY, and year‑to‑date revenue reaching AUD 4.2 million (≈ $2.8 million). Canada showed a dramatic sequential rebound, posting AUD 0.1 million (≈ $0.07 million) in Q3 after...